Cite

    Elsayed, Z. et al. (2021). Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria. Journal of enzyme inhibition and medicinal chemistry. pp. 384-392. [Online].